OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti‐PD‐1/PD‐L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer Immunity
Zhiyong Cai, Jinbo Chen, Zheng-Zheng Yu, et al.
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 43
Zhiyong Cai, Jinbo Chen, Zheng-Zheng Yu, et al.
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 43
Showing 26-50 of 43 citing articles:
Correlation between long non-coding RNA MAFG-AS1 and cancer prognosis: a meta-analysis
Guangyao Lin, Huicong Liu, Jingyu Lin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Guangyao Lin, Huicong Liu, Jingyu Lin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Functional status analysis of RNH1 in bladder cancer for predicting immunotherapy response
Sen Chen, Jun Ran, Zhouqian Fan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Sen Chen, Jun Ran, Zhouqian Fan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
CT-based radiomic phenotypes of lung adenocarcinoma: a preliminary comparative analysis with targeted next-generation sequencing
Xiaowen Liu, Ting Xu, Shuxing Wang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Xiaowen Liu, Ting Xu, Shuxing Wang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Predicting the risk of distant metastasis in patients with locally advanced rectal cancer using model based on pre-treatment T2WI-based radiomic features plus postoperative pathological stage
Chen Wang, Jingjing Chen, Nanxin Zheng, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Chen Wang, Jingjing Chen, Nanxin Zheng, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Development and validation of prognostic index based on purine metabolism genes in patients with bladder cancer
Zixuan Wu, Ziqing Feng, Hongyan Wei, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Zixuan Wu, Ziqing Feng, Hongyan Wei, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 2
A glycosylation risk score comprehensively assists the treatment of bladder neoplasm in the real-world cohort, including the tumor microenvironment, molecular and clinical prognosis
Jinhui Liu, Yunbo He, Weimin Zhou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Jinhui Liu, Yunbo He, Weimin Zhou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
A systematic review and meta-analysis of magnetic resonance and computed tomography enterography in the diagnosis of small intestinal tumors
Ruitao Li, Shengqiang Ye, Chenglong Zhou, et al.
PeerJ (2023) Vol. 11, pp. e16687-e16687
Open Access | Times Cited: 2
Ruitao Li, Shengqiang Ye, Chenglong Zhou, et al.
PeerJ (2023) Vol. 11, pp. e16687-e16687
Open Access | Times Cited: 2
Tumor Mutational Burden as a Biomarker of Immunotherapy Response: An Immunogram Approach in Onco-immunology
Afzal Ansari, Suman Kumar Ray, Mukul Sharma, et al.
Current Molecular Medicine (2023) Vol. 24, Iss. 12, pp. 1461-1469
Closed Access | Times Cited: 2
Afzal Ansari, Suman Kumar Ray, Mukul Sharma, et al.
Current Molecular Medicine (2023) Vol. 24, Iss. 12, pp. 1461-1469
Closed Access | Times Cited: 2
The Impact of Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors: A Case Series on Metastatic Urothelial Carcinoma
Yanyan Zhao, Jun Zhou, Chang Wan, et al.
Research Square (Research Square) (2024)
Open Access
Yanyan Zhao, Jun Zhou, Chang Wan, et al.
Research Square (Research Square) (2024)
Open Access
Role of CAPN5 in Tumor Immune Microenvironment Based on Multi-Omics: From BLCA Molecular Subtypes to Therapeutic Prediction
Yunbo He, Zicheng Xiao, Minghui Hu, et al.
(2024)
Closed Access
Yunbo He, Zicheng Xiao, Minghui Hu, et al.
(2024)
Closed Access
Identification of New Single Nucleotide Polymorphisms Potentially Related to Small Ruminant Lentivirus Infection Susceptibility in Goats Based on Data Selected from High-Throughput Sequencing
Magdalena Materniak-Kornas, Katarzyna Ropka‐Molik, Katarzyna Piórkowska, et al.
Pathogens (2024) Vol. 13, Iss. 10, pp. 830-830
Open Access
Magdalena Materniak-Kornas, Katarzyna Ropka‐Molik, Katarzyna Piórkowska, et al.
Pathogens (2024) Vol. 13, Iss. 10, pp. 830-830
Open Access
MFAP3L predicts tumor microenvironment status, molecular subtypes and clinical benefit in patients with bladder cancer
Guoou Xie, Tiezheng Qi, Yiyan Yao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Guoou Xie, Tiezheng Qi, Yiyan Yao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Editorial: The role of immunophenotype in tumor immunotherapy response
Yujuan Qin, Jian Song
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
Yujuan Qin, Jian Song
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
ACSM6 overexpression indicates a non-inflammatory tumor microenvironment and predicts treatment response in bladder cancer: results from multiple real-world cohorts
Zhiwei Li, Yiyan Yao, Tiezheng Qi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1
Zhiwei Li, Yiyan Yao, Tiezheng Qi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1
Up-regulated serum lactate dehydrogenase could become a poor prognostic marker in patients with bladder cancer by an evidence-based analysis of 2,182 patients
Xiaoyu Wei, Yumeng Chai, Zhouyue Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Xiaoyu Wei, Yumeng Chai, Zhouyue Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Selective multimodal bladder-sparing therapy for muscle-invasive bladder cancer: the present and the future
Fumitaka Koga
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 11, pp. 1127-1139
Closed Access | Times Cited: 1
Fumitaka Koga
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 11, pp. 1127-1139
Closed Access | Times Cited: 1
Three versus four cycles of neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and meta-analysis
Yulong Wang, Yuxuan Song, Caipeng Qin, et al.
Annals of Medicine (2023) Vol. 55, Iss. 2
Open Access | Times Cited: 1
Yulong Wang, Yuxuan Song, Caipeng Qin, et al.
Annals of Medicine (2023) Vol. 55, Iss. 2
Open Access | Times Cited: 1
Role of the tumour microenvironment in bladder cancer pathogenesis and value of the reverse translational approach: a tale of two species
Basant H. Ahmed, Christopher Zdyrski, John C. Cheville, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 5
Open Access
Basant H. Ahmed, Christopher Zdyrski, John C. Cheville, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 5
Open Access
Novel MSH2 and TSC2 variants in a Chinese family with Lynch syndrome and their synergistic impact in urothelial carcinoma
M J Li, Xingjian Yan, He Liu, et al.
Translational research (2023) Vol. 265, pp. 26-35
Closed Access
M J Li, Xingjian Yan, He Liu, et al.
Translational research (2023) Vol. 265, pp. 26-35
Closed Access
